The Scientific Advisory Team at Applied Genetics Technologies Corporation (AGTC) provides expert guidance and strategic insights on the development and implementation of AAV-based gene therapies for the treatment of rare diseases. Consisting of founders and scientific advisors, the team collaborates to ensure cutting-edge research and clinical trials adhere to the highest scientific and ethical standards.